Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01273623 · ClinicalTrials.gov registry record · Phase 4
The Jetstream G3™ Calcium Study
A Phase 4 study of Peripheral Arterial Disease, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- Phase 4
- Development phase
- 55
- Enrollment target
- 5
- Study locations
NCT01273623: Completed Phase 4 study of Peripheral Arterial Disease, sponsored by Boston Scientific Corporation.
NCT01273623 is a Phase 4 study of Peripheral Arterial Disease that has completed, run by Boston Scientific Corporation. The registered enrollment target is 55 participants, below the 4,206-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (99% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01273623, a Phase 4 study of Peripheral Arterial Disease, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 55 participants
- Enrollment target
- 5
- Study locations
Study Summary
To investigate the treatment effects with the Jetstream G3 System in moderate to severely calcified peripheral artery disease in the common femoral, superficial femoral or popliteal arteries using intravascular ultrasound (IVUS).
Primary Outcome
lumen area change as measured by intravascular ultrasound (IVUS)
Conditions Studied
Interventions
- DEVICE Jetstream Atherectomy System
Study Locations (5)
Arizona
- Arizona Heart Institute - Phoenix
Georgia
- Emory University - Atlanta
Michigan
- St. John Hopital - Detroit
Tennessee
- Mercy Medical Center - Knoxville
Wisconsin
- Wheaton Franciscan Healthcare - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-03 |
| Phase | Phase 4 |
What the finished NCT01273623 record still lists
NCT01273623 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 4,206-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 1 intervention - of which Jetstream Atherectomy System is the first listed.
NCT01273623 lists 5 locations in 5 states (Arizona, Georgia, Michigan).
Frequently Asked Questions
What is clinical trial NCT01273623 about?
NCT01273623 is a clinical study titled "The Jetstream G3™ Calcium Study". To investigate the treatment effects with the Jetstream G3 System in moderate to severely calcified peripheral artery disease in the common femoral, superficial femoral or popliteal arteries using intravascular ultrasound (IVUS).
What is the current status of trial NCT01273623?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 55 participants. The study started on 2011-01. Estimated completion is 2012-03.
What conditions does trial NCT01273623 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease.
What interventions are being tested in trial NCT01273623?
The interventions under investigation include: Jetstream Atherectomy System (DEVICE).
Who is sponsoring clinical trial NCT01273623?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01273623 being conducted?
This trial has 5 study locations across Arizona, Georgia, Michigan, Tennessee, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01273623's enrollment target sits among peer trials
55 51st of 79 higher than 29 of 79 other Peripheral Arterial Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Peripheral Arterial Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis
RECRUITING · Phase 4
-
Vascular Trial Associated Registry Pilot
RECRUITING · Phase 4
-
The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease
ACTIVE NOT RECRUITING · Phase 4
-
SELUTION4BTK Trial
RECRUITING · NA
-
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
RECRUITING · NA
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia